CAS 864445-45-4
:Jwh 302
Description:
JWH-302 is a synthetic cannabinoid that belongs to a class of compounds known as indole-derived cannabinoids. It was developed by Dr. John W. Huffman and is known for its psychoactive properties, mimicking the effects of natural cannabinoids found in cannabis. The chemical structure of JWH-302 allows it to bind to cannabinoid receptors in the brain, particularly CB1 and CB2 receptors, which are involved in various physiological processes, including mood regulation, pain sensation, and appetite. JWH-302 is often associated with research in pharmacology and toxicology, but it has also been identified in various designer drug products. Its use can lead to a range of effects, including euphoria, altered perception, and potential adverse reactions. Due to its synthetic nature and the potential for abuse, JWH-302 is subject to legal restrictions in many jurisdictions. Safety and toxicity profiles are still being studied, and users should be aware of the risks associated with synthetic cannabinoids, which can differ significantly from natural cannabis.
Formula:C22H25NO2
InChI:InChI=1S/C22H25NO2/c1-3-4-7-13-23-16-20(19-11-5-6-12-21(19)23)22(24)15-17-9-8-10-18(14-17)25-2/h5-6,8-12,14,16H,3-4,7,13,15H2,1-2H3
InChI key:InChIKey=XZVYWLVYUAQEIM-UHFFFAOYSA-N
SMILES:C(CC1=CC(OC)=CC=C1)(=O)C=2C=3C(N(CCCCC)C2)=CC=CC3
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.
JWH-302
CAS:Controlled ProductJWH-302 is a synthetic cannabinoid that has been shown to have binding affinity for the CB2 receptor. It is used in cell culture to study the effects of cannabinoids on receptors and has been shown to be active in urine samples from patients with symptoms of chronic pain, cachexia, or fibromyalgia. JWH-302 was also found to have linear regression analysis and human liver activity. Its effect on fatty acid metabolism may be due to its ability to inhibit mitochondrial beta-oxidation and increase fatty acid synthesis. JWH-302 also binds with high affinity to the CB1 receptor, but it is not active at this site. This drug has been shown to cause a matrix effect that can be eliminated by increasing the concentration of dioxane in the sample preparation buffer. The chemical ionization mode was used for detection with a spectrometer.br>br> JWH-302 binds with high affinity to the CB2 receptor, but it is not active at this site. ThisPurity:Min. 95%
